PharmaCept in research

PharmaCept initiates and supports clinical and experimental research projects in the fields of locoregional tumor therapy/chemoembolization of primary and secondary liver and lung tumors as well as the treatment of non-muscle-invasive bladder carcinoma.

In the future, PharmaCept will also invest in the development of further therapeutic options for the treatment of non-muscle invasive bladder cancer.

 

Clinical Research

The research focus of PharmaCept is particularly in the field of chemoembolization of liver and lung tumors with EmboCept® S.

In cooperation with universities and other research institutions, we initiate and support the following research areas:

  • Chemoembolization of tumors and their combination with other locoregional and systemic tumor therapy regimens for liver and lung tumors
  • Chemo- and immuno-instillation of non-muscle-invasive bladder tumors

 

Experimental Research

The research focus of PharmaCept lies in the areas of locoregional tumor therapy/chemoembolization of liver and lung tumors with EmboCept® S. In cooperation with universities and other research institutions, PharmaCept initiates and supports the following research areas:

  • Basics of Organ Immunology under Locoregional Tumor Therapy Concepts
  • Pharmacokinetics of intraarterially applied tumor agents
  • Locoregional gene therapeutic approaches
  • Tumor vascularization and neoangiogenesis under ischemia
PharmaCept in research